Maternal syphilis: Pathophysiology and treatment

Bulletin of the World Health Organization

Volumn 82, Issue 6, 2004, Pages 433-438

  Berman, Stuart M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Disease transmission, Vertical prevention and control; Pregnancy complications, Infectious drug therapy; Pregnancy outcome; Syphilis, Congenital cerebrospinal fluid physiopathology prevention and control; Syphilis diagnosis drug therapy transmission

Indexed keywords

BENZATHINE PENICILLIN; CEFTRIAXONE; PROCAINE PENICILLIN;

PREGNANCY;

BACTERIAL GENOME; BREATHING DISORDER; DRUG HYPERSENSITIVITY; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INTRAUTERINE INFECTION; NEWBORN INFECTION; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; RABBIT; RASH; REVIEW; SPIROCHETE; SYPHILIS; THIRD TRIMESTER PREGNANCY;

DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL DEATH; FETAL DISEASES; GESTATIONAL AGE; HUMANS; PENICILLIN G, BENZATHINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; SYPHILIS, CONGENITAL; TREPONEMA PALLIDUM;

EID: 3042674211     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Hutchinson J. On the different forms of the inflammation of the eye consequent on inherited syphilis. Ophthalmol Hosp Rev 1858;1:191.
2. Nabarro D. Congenital syphilis. London: Edward Arnold; 1954.
3. Fraser CM, Norris SJ, Weinstock GM, White O, Sutton GG, Dodson R, et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 1998;281:375-88.
4. Radolff JD, Steiner B, Shevchenko D. Treponema pallidum: doing a remarkable job with what it's got. Trends in Microbiology 1999;7:7-9.
5. Ingall D, Sanchez PJ. Syphilis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newbom infant. 5th ed. Philadelphia: Saunders; 2001. p. 643-81.
6. Pennisi E. Genome reveals wiles and weak points of syphilis. Science 1998;281:324-5.
7. Weinstock GM, Hardham JM, McLeod MP, Sodergren EJ, Norris SJ. The genome of Treponema pallidum: new light on the agent of syphilis. FEMS Microbiology Reviews 1998;22:323-32.
8. Magnusen JH, Eagle H, Fleischman R. Minimal infectious inoculum of Spirochaeta pallida (Nichols strain) and a consideration of its rate of multiplication in vivo. American Journal of Syphilis, Gonorrhea, and Venereal Diseases 1948;32:1-18.
9. Idsoe O, Guthe T, Willcox RR. Penicillin in the treatment of syphilis: the experience of three decades. Bulletin of the World Health Organization 1972;47:1-68.
10. Ingraham NR. The value of penicillin alone in the prevention and treatment of congenital syphilis. Acta Dermato-venereologica 1951;31 Suppl 24:60.
11. Zenker PN, Berman SM. Congenital syphilis: trends and recommendations for evaluation and management. Pediatric Infectious Disease Journal 1991;10:516-22.
12. Radolf JD, Sanchez PJ, Schulz KF, Murphy FK. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN, editors. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill; 1999. p. 1165-89.
13. Dippel AL. The relationship of congenital syphilis to abortion and miscarriage, and the mechanism of intrauterine protection. American Journal of Obstetrics and Gynecology 1944;47:369.
14. Benirschke K. Syphilis - the placenta and the fetus. American Journal of Diseases of Children 1974;128:142-3.
15. Harter CA, Benirschke K. Fetal syphilis in the first trimester. American Journal of Obstetrics and Gynecology 1976;124:705-11.
16. Nathan L, Bohman VR, Sanchez PJ, Leos NK, Twickler DM, Wendel GD. In utero infection with Treponema pallidum in early pregnancy. Prenatal Diagnosis 1997;17:119-23.
17. Radolf JD, Norgard MV, Brandt ME, Isaacs RD, Thompson PA, Beutler B. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachetin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. Journal of Immunology 1991;147:1968-74.
18. Riley BS, Oppenheimer-Marks N, Hansen EJ, Radolf JD, Norgard MV. Virulent Treponema pallidum activates human vascular endothelial cells. Journal of Infectious Diseases 1992;165:484-93.
19. Norgard MV, Riley BS, Richardson JA, Radolf JD. Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins. Infection and Immunity 1995;63:1507-15.
20. Russell P, Altschuler G, Placental abnormalities of congenital syphilis. American Journal of Diseases of Children 1974;128:160-3.
21. Oppenheimer EH, Hardy JB. Congenital syphilis in the newborn infant: clinical and pathological observations in recent cases. Johns Hopkins Medical Journal 1971;129:63-82.
22. Morrison JE. Foetal and neonatal pathology. New York: Appleton-Century-Crofts; 1970.
23. Kaplan BS, Wiglesworth FW, Marks MI, Drummond KN. The glomerulopathy of congenital syphilis - an immune deposit disease. Journal of Pediatrics 1972;81:1154-6.
24. Cremin BJ, Fisher RM. The lesions of congenital syphilis. British Journal of Radiology 1970;43:333-41.
25. Silverstein AM. Congenital syphilis and the timing of immunogenesis in the human fetus. Nature 1962;194:196.
26. Daffos F, Forestier F, Grangeot-Keros L, Capella Pavlovsky M, Lebon P, Chartier M, et al. Prenatal diagnosis of congenital rubella. Lancet 1984;2:1-3.
27. Lewis DB, Wilson CB. Developmental immunology and role of host defenses in neonatal susceptibility to infection. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newbom infant. 4th ed. Philadelphia: Saunders; 1995. p. 20-98.
28. Hollier LM, Harstad TW, Sanchez PJ, Twickler DM, Wendel GD Jr. Fetal syphilis: clinical and laboratory characteristics. Obstetrics and Gynecology 2001;97:947-53.
29. Platou RV. Treatment of congenital syphilis with penicillin. Advances in Pediatrics 1949;4:35.
30. Michelow IC, Wendel GD Jr, Norgard MV, Zeray F, Leos NK, Alsaadi R, et al. Central nervous system infection in congenital syphilis. New England Journal of Medicine 2002;346:1792-8.
31. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. Morbidity and Mortality Weekly Report 2002;51:1-78.
32. World Health Organization. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2001. WHO document WHO/RHR/01.10. Available from: http://www.who.int/ docstore/hiv/ STIManagemntguidelines/who_hiv_aids_2001.01/
33. Crowe G, Theodore C, Forster GE, Goh BT. Acceptability and compliance with daily injections of procaine penicillin in the outpatient treatment of syphilis - treponemal infection. Sexually Transmitted Diseases 1997;24:127-30.
34. Monif GR. Is current therapy for maternal syphilis inadequate for established fetal infection? American Journal of Obstetrics and Gynecology 1994;170:705.
35. Walker GJA. Antibiotics for syphilis diagnosed during pregnancy. The Cochrane Library 2001;Issue 4.
36. Wendel GD Jr, Sheffield JS, Hollier LM, Hill JB, Ramsey PS, Sanchez PJ. Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clinical Infectious Diseases 2002;35 Suppl 2:S200-9.
37. Watson-Jones D, Changalucha J, Gumodoka B, Weiss H, Rusizoka M, Ndeki L, et al. Syphilis in pregnancy in Tanzania, I. Impact of maternal syphilis on outcome of pregnancy. Journal of Infectious Diseases 2002;186:940-7.
38. Watson-Jones D, Gumodoka B, Weiss H, Changalucha J, Todd J, Mugeye K, et al. Syphilis in pregnancy in Tanzania. II. The effectiveness of antenatal syphilis screening and single-dose benzathine penicillin treatment for the prevention of adverse pregnancy outcomes. Journal of Infectious Diseases 2002;186:948-57.
39. Donders GG, Desmyter J, Hooft P, Dewet GH. Apparent failure of one injection of benzathine penicillin G for syphilis during pregnancy in human immunodeficiency virus-seronegative African women. Sexually Transmitted Diseases 1997;24:94-101.
40. Wilkinson D, Sach M, Connolly C. Epidemiology of syphilis in pregnancy in rural South Africa: opportunities for control. Tropical Medicine and International Health 1997;2:57-62.
41. Alexander JM, Sheffield JS, Sanchez PJ, Mayfield J, Wendel GD Jr. Efficacy of treatment for syphilis in pregnancy, Obstetrics and Gynecology 1999;93:5-8.
42. Terris-Prestholt F, Watson-Jones D, Mugeye K, Kumaranayake L, Ndeki L, Weiss H, et al. Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sexually Transmitted Infections 2003;79:375-81.
43. Robinson JL, Hameed T, Carr S. Practical aspects of choosing an antibiotic for patients with a reported allergy to an antibiotic. Clinical Infectious Diseases 2002;35:26-31.
44. Kerr JR. Penicillin allergy: a study of incidence as reported by patients. British Journal of Clinical Practice 1994;48:5-7.
45. Gust DA, Levine WC, St Louis ME, Braxton J, Berman SM. Mortality associated with congenital syphilis in the United States, 1992-1998. Pediatrics 2002;109:E79. Available from URL: http://pediatrics. aappublications.org/cgi/ content/abstract/109/5/e79
46. Mascola L, Pelosi R, Alexander CE. Inadequate treatment of syphilis in pregnancy. American Journal of Obstetrics and Gynecology 1984;150:945-7.
47. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG: an International Journal of Obstetrics and Gynaecology 2002;107:770-5.
48. Yinnon AM, Coury-Doniger P, Polito R, Reichman RC. Serologic response to treatment of syphilis in patients with HIV infection. Archives of Internal Medicine 1996;156:321-5.
49. Rolfs RT, Joesoef MR, Hendershot EF, Rompalo AM, Augenbraun MH, Chiu M, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. New England Journal of Medicine 1997;337:307-14.